William Blair & Company’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,723
| Closed | -$807K | – | 1817 |
|
|
2024
Q3 | $807K | Sell |
12,723
-2,309
| -15% | -$167K | ﹤0.01% | 966 |
|
|
2024
Q2 | $1.02M | Buy |
15,032
+4,050
| +37% | +$283K | ﹤0.01% | 872 |
|
|
2024
Q1 | $870K | Buy |
10,982
+12
| +0.1% | +$981 | ﹤0.01% | 913 |
|
|
2023
Q4 | $853K | Buy |
10,970
+31
| +0.3% | +$2.29K | ﹤0.01% | 906 |
|
|
2023
Q3 | $769K | Hold |
10,939
| – | – | ﹤0.01% | 920 |
|
|
2023
Q2 | $871K | Buy |
10,939
+1,546
| +16% | +$112K | ﹤0.01% | 884 |
|
|
2023
Q1 | $679K | Sell |
9,393
-154
| -2% | -$12K | ﹤0.01% | 943 |
|
|
2022
Q4 | $786K | Sell |
9,547
-3,563
| -27% | -$294K | ﹤0.01% | 911 |
|
|
2022
Q3 | $1.02M | Buy |
13,110
+398
| +3% | +$31.8K | ﹤0.01% | 806 |
|
|
2022
Q2 | $860K | Sell |
12,712
-435
| -3% | -$30.3K | ﹤0.01% | 900 |
|
|
2022
Q1 | $862K | Sell |
13,147
-234
| -2% | -$13.6K | ﹤0.01% | 972 |
|
|
2021
Q4 | $812K | Sell |
13,381
-6,933
| -34% | -$413K | ﹤0.01% | 1032 |
|
|
2021
Q3 | $1.3M | Sell |
20,314
-1,686
| -8% | -$106K | ﹤0.01% | 823 |
|
|
2021
Q2 | $1.38M | Buy |
22,000
+282
| +1% | +$17.7K | ﹤0.01% | 816 |
|
|
2021
Q1 | $1.24M | Buy |
21,718
+5,563
| +34% | +$301K | ﹤0.01% | 833 |
|
|
2020
Q4 | $812K | Buy |
16,155
+8,059
| +100% | +$321K | ﹤0.01% | 931 |
|
|
2020
Q3 | $239K | Sell |
8,096
-1,709
| -17% | -$49.6K | ﹤0.01% | 1221 |
|
|
2020
Q2 | $246K | Buy |
+9,805
| New | +$245K | ﹤0.01% | 1165 |
|
|
2020
Q1 | – | Sell |
-10,390
| Closed | -$345K | – | 1653 |
|
|
2019
Q4 | $345K | Sell |
10,390
-5,140
| -33% | -$161K | ﹤0.01% | 1127 |
|
|
2019
Q3 | $483K | Hold |
15,530
| – | – | ﹤0.01% | 956 |
|
|
2019
Q2 | $543K | Buy |
15,530
+3
| +0% | +$97 | ﹤0.01% | 950 |
|
|
2019
Q1 | $455K | Sell |
15,527
-2,050
| -12% | -$58.1K | ﹤0.01% | 993 |
|
|
2018
Q4 | $452K | Sell |
17,577
-7,660
| -30% | -$265K | ﹤0.01% | 940 |
|
|
2018
Q3 | $888K | Hold |
25,237
| – | – | 0.01% | 782 |
|
|
2018
Q2 | $1.03M | Sell |
25,237
-4,070
| -14% | -$164K | 0.01% | 715 |
|
|
2018
Q1 | $1.15M | Sell |
29,307
-4,335
| -13% | -$159K | 0.01% | 677 |
|
|
2017
Q4 | $1.1M | Sell |
33,642
-17,633
| -34% | -$611K | 0.01% | 722 |
|
|
2017
Q3 | $2.45M | Buy |
51,275
+38,406
| +298% | +$1.87M | 0.02% | 507 |
|
|
2017
Q2 | $635K | Buy |
12,869
+4,524
| +54% | +$200K | ﹤0.01% | 897 |
|
|
2017
Q1 | $365K | Buy |
+8,345
| New | +$339K | ﹤0.01% | 1005 |
|
Other funds holding ACHC
PCP
MAP
William Blair & Company's ACHC Position: Q4 2024 in Review
William Blair & Company sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 12,723 shares — an estimated $807K sold.
William Blair & Company first reported a position in ACHC in Q1 2017 and held it in 30 quarters. The position peaked at $2.45M in Q3 2017. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.
- William Blair & Company reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
- William Blair & Company sold 12,723 Acadia Healthcare shares in Q4 2024, an estimated $807K.
- William Blair & Company first reported a position in Acadia Healthcare in Q1 2017 and held it in 30 quarters.
- William Blair & Company's Acadia Healthcare position peaked at $2.45M in Q3 2017.
- 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.
Based on William Blair & Company's 13F filing for Q4 2024, filed 12 Feb 2025.